Effects of radiofrequency ablation and complete endoscopic resection are...
According to a new systematic review article, radiofrequency ablation and complete endoscopic resection are equally effective in the short-term treatment of dysplastic Barrett's esophagus, but adverse...
View ArticleUCB, Dermira enter into licensing agreement for development,...
UCB, a global biopharmaceutical leader, and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the...
View ArticleMetvix PDT now available at Odette Cancer Centre as additional treatment...
The Odette Cancer Centre at Sunnybrook Health Sciences Centre in conjunction with Galderma Canada are pleased to announce that Metvix PDT (Photodynamic Therapy), is now available at the Odette Cancer...
View ArticleConcordia subsidiary enrolls patients in Phase 2 trial to evaluate PDT with...
Concordia Healthcare Corp., a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, announced today that its subsidiary...
View ArticleVersatile nanoparticles offer wide variety of diagnostic and therapeutic...
Kit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer.
View ArticleConcordia signs collaboration agreement with Orphan Canada for PHOTOFRIN
Concordia Healthcare Corp., a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today announced that its subsidiary,...
View ArticleSoligenix acquires novel orphan drug candidate for treatment of CTCL
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a...
View ArticlePinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile...
Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announced today the initiation of the pivotal Phase 3 trial (OPUS) in Germany for a rare form of bile duct cancer for which there...
View ArticleScientists combine new type of nanoparticle with photodynamic therapy to kill...
An international group of scientists led by Gang Han, PhD, at the University of Massachusetts Medical School, has combined a new type of nanoparticle with an FDA-approved photodynamic therapy to...
View ArticleConcordia Healthcare reports record revenues of 147% in third quarter 2014
Concordia Healthcare Corp. ("Concordia" or the "Company"), a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today...
View ArticleTreating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO,...
Wet AMD is characterized by abnormal growth of blood vessels in the macula (the area of the eye containing vision-enabling photoreceptors), and is responsible for the vast majority of severe vision...
View ArticleSoligenix's SGX301 receives FDA 'Fast Track' designation for CTCL treatment
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its SGX301...
View ArticleStudy shows how PDT for pancreatic cancer can be included in physician...
Late stage pancreatic cancer benefits from photodynamic therapy (PDT) but the resources needed for the usual accompanying dosimetry present barriers, Dartmouth researchers Jonathan T. Elliott, PhD and...
View ArticleFujifilm enters into definitive agreement to acquire Cellular Dynamics...
FUJIFILM Holdings Corporation (President: Shigehiro Nakajima) and Cellular Dynamics International, Inc. (CEO: Robert J. Palay), a leading developer and manufacturer of fully functioning human cells in...
View ArticleScientists develop new type of carrier that combines photosensitivity and...
By combining, in a liposome, magnetic nanoparticles and photosensitizers that are simultaneously and remotely activated by external physical stimuli (a magnetic field and light), scientists at the...
View ArticleUniversity of York scientists use low temperature plasmas to treat prostate...
Scientists at the University of York have discovered a potential new treatment for prostate cancer using low temperature plasmas (LTPs).
View ArticleMesothelioma.us releases new case study that focuses on experimental...
Mesothelioma.us, an educational and authoritative website that offers free and in-depth resources for mesothelioma patients and their families, has just released a new case study that focuses on the...
View ArticleRPCI receives NCI grant to continue research program on photodynamic therapy...
Roswell Park Cancer Institute has received continuation of a prestigious program project grant from the National Cancer Institute for research through the Roswell Park Photodynamic Therapy Center.
View ArticlePolypoidal choroidal vasculopathy shows distinct classification
Researchers have found that idiopathic polypoidal choroidal vasculopathy has significant clinical differences to neovascular age-related macular degeneration and suggest that it should be considered a...
View ArticleCurrent and new treatments for AMD: an interview with Dr Alan Cruess, AMD...
For two decades beginning in the late 1970’s through 2001, clinicians relied upon laser photocoagulation in the treatment of wet AMD caused by choroidal neovascularization. Attempts to obliterate the...
View Article